概括
人工智能 (AI) 正在改变医疗保健,特别是心脏病. 这篇文章探讨了AI.
科学领域:
- 心脏病学 心脏病学
- 医疗技术 医疗技术 医学技术
- 人工智能的人工智能
背景情况:
- 人工智能 (AI) 算法越来越多地影响包括医疗保健在内的各个行业的决策.
- 人工智能的普遍性质引发了伦理,问责和准确性的担忧,特别是当涉及患者的结果时.
研究的目的:
- 检查AI在心脏病学中的当前应用.
- 探索AI在心血管保健中的潜在未来扩展.
- 概述安全有效地在医疗保健中部署人工智能的合作策略.
主要方法:
- 审查目前的心脏病学中的AI应用.
- 分析潜在的未来AI在心血管医学中的使用案例.
- 讨论人工智能实施的伦理和实际考虑.
主要成果:
- 人工智能目前被用于心脏病学的各个方面,影响决策.
- 人工智能在心脏病学中的应用范围预计将不断增长.
- 医疗保健专业人员和技术人员之间的合作至关重要.
结论:
- 人工智能在心脏病学中的整合既带来了机遇,也带来了挑战.
- 确保患者安全,效率和益处需要仔细部署人工智能.
- 多学科合作是利用人工智能的潜力在心血管保健中的关键.
相关概念视频
Increased pulse rate
635
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
635
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
126
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
126
Imaging Studies for Cardiovascular System I:Echocardiography
280
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
280
Heart Failure Drugs: Inotropic Agents
495
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
495


